alexa Fertility Sparing Approach In Young Patients With Early Stages Of Endometrial Cancer
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

16th Global Annual Oncologists Meeting
April 24-25, 2017 Dubai, UAE

Katarina Jeremic
University of Belgrade, Serbia
ScientificTracks Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-096
Abstract
Endometrial cancer is the most common cancer of female genital tract and female patients less than 40 years may account for 3-14% of all endometrial cancers. The promising fact is that in women <45 years, the tumor is mostly low grade disease localised to the endometrium, whereas survival is almost about 100%. An individualized and multidisciplinary approach to each patient and intense follow-ups are the current recommendations for fertility sparing. Conservative approaches of earlystage endometrial carcinoma includes hormonal therapy in selected group of young patients with endometrial carcinoma, age less than 45 years and wishes fertility, showing low grade 1 endometrioid adenocarcinomas (by 2 gynoncology pathologists review) limited to the endometrium with MRI excluded myomaterial invasion, without evidence of limphovasculare space involvement or extra uterine disease. Careful and accurate pretreatment assessment of patients considering conservative therapy includes radiologic imaging, hysteroscopy preferably but also contrast-enhanced radiologic imaging -MRI imaging of the ovary (5% of patients with endometrial cancer have synchronous primaries tumors). Repeating endometrial biopsies by hysteroscopy every 6 months has been recommended, until there is a complete response or achieving pregnancy. Surgery is recommended if there is no response after 6 months of medicational treatment. Hormonal therapy that could be applied is progestins which inhibits the estrogenic effect and suppresses cell proliferation (medroxy progesterone acetate, megestrl acetate), GnRh analogues, local gestagens (IUD), oral natural progesterons, aromatase inhibitors, even three step endoscopic (hysteroscopic) resection - removing tumour surrounding endometrium and myometrium. Fertility after treatment is not guaranteed, even there had been recorded reduced fertility of those treated, and there is a significant need of ART (18-60%).
Biography

Katarina Jeremic has completed his PhD from University in Belgrade, Serbia, She is the Chief of Gynecologic Oncology Department at Clinic of Ob/Gyn, Clinical Center of Serbia and member of many scientific projects related to Cancer and Pregnancy. She works as a Lecturer/Associate Professor of Gynecology and Obstetrics at the Medical School, University Belgrade. She has 50 publications in CC/SCI expanded and JCR indexed. She is an acitive participant at more than 50 international congresses, with total number of publications about 150.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords